Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
BRVE Insider Trading and Fund Holdings (Braveheart Bio, Inc.) · https://wallstpal.com/stock/brve/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 2131524

Braveheart Bio, Inc. (BRVE): Insider Trades and Fund Holdings

In the past 12 months, Braveheart Bio, Inc. insiders reported 11 open-market purchases worth $159.0M and no sales.

11Insider buys, 12 months
$159.0MBought by insiders, 12 months
$0Sold by insiders, 12 months
0Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Aug 7, 2026Insider buyDirector Orbimed Advisors LLC bought $34.9 million
  2. Aug 7, 2026Insider buyDirector Erez Chimovits bought $34.9 million
  3. Aug 7, 2026Insider buy10% owner Ah Bio Fund Iv, L.P. bought $19.8 million
  4. Aug 7, 2026Insider buy10% owner Forbion Growth Opportunities Fund III Cooperatief U.a. bought $64.8 million
  5. Aug 7, 2026Insider buyCEO Travis Murdoch bought $1.5 million
  6. Aug 7, 2026Insider buyDirector Christopher Viehbacher bought $1.5 million
  7. Aug 7, 2026Insider buyDirector David Charles Lubner bought $999,990
  8. Aug 7, 2026Insider buyCFO James Paul Rickey bought $499,986
  9. Aug 7, 2026Insider buyDirector David I. Malek bought $74,988
  10. Aug 7, 2026Insider buyChief Development Officer Michele A. Anderson bought $19,998

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Aug 11, 2026.

Recent BRVE insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHoldingFiling
Aug 11Aug 7Orbimed Advisors LLCDirectorDirector (ind.)▲ BUY1,940,00018.00$34.9M62NewForm 4 ↗
Aug 11Aug 7Erez ChimovitsDirectorDirector (ind.)▲ BUY1,940,00018.00$34.9M62NewForm 4 ↗
Aug 11Aug 7Ah Bio Fund Iv, L.P.10% owner10% owner (ind.)▲ BUY1,100,00018.00$19.8M48+12%Form 4 ↗
Aug 7Aug 7Forbion Growth Opportunities Fund III Cooperatief U.a.10% owner10% owner▲ BUY1,920,00018.00$34.6M48+20%Form 4 ↗
Aug 7Aug 7Forbion Growth Opportunities Fund III Cooperatief U.a.10% owner10% owner (ind.)▲ BUY1,680,00018.00$30.2M48+20%Form 4 ↗
Aug 7Aug 7Travis MurdochCEOCEO▲ BUY83,33318.00$1.50M49+2.9%Form 4 ↗
Aug 7Aug 7Christopher ViehbacherDirectorDirector▲ BUY83,33318.00$1.50M49+16%Form 4 ↗
Aug 7Aug 7David Charles LubnerDirectorDirector▲ BUY55,55518.00$1000K56NewForm 4 ↗
Aug 7Aug 7James Paul RickeyCFOCFO▲ BUY27,77718.00$500K46+5.6%Form 4 ↗
Aug 7Aug 7David I. MalekDirectorDirector▲ BUY4,16618.00$75K29+0.8%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 11 BRVE insider trades →

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Orbimed Advisors LLCDirector1$34.9M0$0Aug 11, 2026
Erez ChimovitsDirector1$34.9M0$0Aug 11, 2026
Ah Bio Fund Iv, L.P.10% owner1$19.8M0$0Aug 11, 2026
Forbion Growth Opportunities Fund III Cooperatief U.a.10% owner2$64.8M0$0Aug 7, 2026
Travis MurdochCEO1$1.50M0$0Aug 7, 2026
Christopher ViehbacherDirector1$1.50M0$0Aug 7, 2026
David Charles LubnerDirector1$1000K0$0Aug 7, 2026
James Paul RickeyCFO1$500K0$0Aug 7, 2026
Strongest purchase, 12 months

62 Orbimed Advisors LLC (Director), 2026-08-07. What the score means

Filing quality

A All 11 insider trades reported on time. How it is graded

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →